Compare IRTC & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | ARCB |
|---|---|---|
| Founded | 2006 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.4B |
| IPO Year | 2016 | 1994 |
| Metric | IRTC | ARCB |
|---|---|---|
| Price | $126.20 | $134.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $197.92 | $122.75 |
| AVG Volume (30 Days) | ★ 706.5K | 359.7K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $747,138,000.00 | ★ $1,657,864,000.00 |
| Revenue This Year | $19.60 | $7.00 |
| Revenue Next Year | $15.94 | $5.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.24 | 12.56 |
| 52 Week Low | $100.85 | $59.43 |
| 52 Week High | $210.01 | $176.69 |
| Indicator | IRTC | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 41.40 |
| Support Level | $104.17 | $112.62 |
| Resistance Level | $136.70 | $135.10 |
| Average True Range (ATR) | 6.64 | 6.21 |
| MACD | 0.20 | -0.42 |
| Stochastic Oscillator | 52.44 | 14.70 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.